Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1-Reference-Cited by-同舟云学术

Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1

Published:1998-04-01 Issue:4 Volume:83 Page:1325-1335
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Ricketts Marie L.,Verhaeg Julie M.,Bujalska Iwona,Howie Alexander J.¹,Rainey William E.²,Stewart Paul M.

Affiliation:

1. Departments of Medicine and Pathology, University of Birmingham, Queen Elizabeth Hospital (A.J.H.), Edgbaston, Birmingham, United Kingdom B15 2TH;

2. the Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center (W.E.R.), Dallas, Texas 75235-7200

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/83/4/1325/10442993/jcem1325.pdf

Reference37 articles.

1. The human gene for 11β-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localisation.;Tannin;J Biol Chem,1991

2. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme;Albiston;Mol Cell Endocrinol.,1994

3. Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity NAD-dependent enzyme and differs from the cloned “type 1” isoform.;Stewart;J Clin Endocrinol Metab,1994

4. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations.;Jamieson;Endocrinology,1995

5. Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes.;Ricketts;J Endocrinol,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target‐Mediated Drug Disposition Model;The Journal of Clinical Pharmacology;2024-04-23

2. Glucocorticoid regulation of cancer development and progression;Frontiers in Endocrinology;2023-04-18

3. Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity;Diabetes, Obesity and Metabolism;2022-12-22

4. Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe;Frontiers in Endocrinology;2021-08-27

5. EMERGENCE OF BENZOTHIAZOLE AND ITS DERIVATIVES AS A POTENTIAL ANTIDIABETIC PROBE;INDIAN DRUGS;2020-10-08